PEAK6 Investments’s Takeda Pharmaceutical TAK Stock Holding History

PEAK6 Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.03M	Sell	143,100 -84,400	-37%	-$1.2M	﹤0.01%	1496
2024 Q2	$2.94M	Buy	227,500 +134,400	+144%	+$1.78M	0.01%	1128
2024 Q1	$1.29M	Buy	+93,100	New	+$1.35M	﹤0.01%	1752
2023 Q1	–	Sell	-628,900	Closed	-$9.81M	–	4959
2022 Q4	$9.81M	Buy	+628,900	New	+$8.78M	0.06%	384
2021 Q1	–	Sell	-100,000	Closed	-$1.82M	–	5513
2020 Q4	$1.82M	Hold	100,000	–	–	﹤0.01%	1930
2020 Q3	$1.78M	Hold	100,000	–	–	﹤0.01%	1764
2020 Q2	$1.79M	Buy	100,000 +70,000	+233%	+$1.26M	0.01%	1583
2020 Q1	$455K	Sell	30,000 -41,246	-58%	-$748K	﹤0.01%	2158
2019 Q4	$1.41M	Hold	71,246	–	–	0.01%	1321
2019 Q3	$1.23M	Buy	71,246 +33,046	+87%	+$572K	0.01%	1604
2019 Q2	$676K	Buy	38,200 +30,000	+366%	+$546K	﹤0.01%	2065
2019 Q1	$167K	Buy	+8,200	New	+$165K	﹤0.01%	3023

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

PEAK6 Investments's TAK Position: Q3 2024 in Review

PEAK6 Investments reduced its Takeda Pharmaceutical (TAK) stake by 100% in Q3 2024, selling an estimated $1.12M and leaving 273 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3277.

PEAK6 Investments first reported a position in TAK in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.03M in Q2 2024. 298 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

PEAK6 Investments held 273 shares of Takeda Pharmaceutical worth $3.88K as of Q3 2024.
PEAK6 Investments sold 79,234 Takeda Pharmaceutical shares in Q3 2024, an estimated $1.12M.
Takeda Pharmaceutical made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3277 holding.
PEAK6 Investments first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 11 quarters since.
PEAK6 Investments's Takeda Pharmaceutical position peaked at $1.03M in Q2 2024.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.